Paraneoplastic neuromyelitis optica spectrum disorders: a case series.

Aquaporin-4 Neuromyelitis optica spectrum disorders Optic neuritis Paraneoplastic syndrome Transverse myelitis

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 20 09 2020
accepted: 11 01 2021
pubmed: 29 1 2021
medline: 1 6 2021
entrez: 28 1 2021
Statut: ppublish

Résumé

Aquaporin-4 antibody (AQP4-IgG) neuromyelitis optica spectrum disorders (NMOSD) are rare idiopathic autoimmune diseases, presenting with optic neuritis (ON), longitudinally extensive transverse myelitis (LETM), and brainstem syndromes and a prevalence range between 0.5 and 4/100,000. Only 3% to 25% of NMOSD have been described as a paraneoplastic (PN) syndrome (PNNMOSD). Both idiopathic NMOSD (INMOSD) and PNNMOSD cases mostly affect females, but PNNMOSD usually presents with a spinal cord or brainstem involvement in elderly patients. Few cases of both malignancies (for the majority breast or lung cancer) and benign tumors (monoclonal gammopathy) were previously reported. Currently, there is no consensus on treatment approach for PNNMOSD (only surgical removal or surgery combined with chronic immunosuppression). Here, we present a series of three newly diagnosed PNNMOSD cases, who differ from each other for demographic and clinical features, tumor association, long-term treatment, and outcome. We propose that a PN etiology should be considered always whenever a new diagnosis of NMOSD is made, not only in patients over 50 years old or in spinal cord/brainstem lesions presentations. Our findings add to existing evidence and raise awareness on PNNMOSD. We enhance the importance for the clinicians of recognizing tumor symptoms and signs whenever a NMOSD is newly diagnosed.

Identifiants

pubmed: 33506301
doi: 10.1007/s10072-021-05055-y
pii: 10.1007/s10072-021-05055-y
doi:

Substances chimiques

Aquaporin 4 0
Autoantibodies 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2519-2522

Références

Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Sillevis Smitt P, Vedeler CH, Verschuuren JJGM, Vincent A, Voltz R, for the Paraneoplastic Neurological Syndrome Euronetwork (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140. https://doi.org/10.1136/jnnp.2003.034447
doi: 10.1136/jnnp.2003.034447 pubmed: 15258215 pmcid: 1739186
Zoccarato M, Gastaldi M, Zuliani L, Biagioli T, Brogi M, Bernardi G, Corsini E, Bazzigaluppi E, Fazio R, Giannotta C, Nobile-Orazio E, Costa G, Iorio R, Evoli A, Mariotto S, Ferrari S, Galloni E, De Riva V, Zardini E, Franciotta D, Giometto B (2017) Diagnostics of paraneoplastic neurological syndromes. Neurol Sci 38:237–242. https://doi.org/10.1007/s10072-017-3031-5
doi: 10.1007/s10072-017-3031-5 pubmed: 29030766
Cai G, He D, Chu L, Dai Q, Xu Z, Zhang Y (2016) Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Int J Neurosci 126:660–668. https://doi.org/10.3109/00207454.2015.1054481
doi: 10.3109/00207454.2015.1054481 pubmed: 26010208
Sepulveda M, Sola-Valls N, Escudero D, Rojc B, Barón M, Hernández-Echebarría L, Gómez B, Dalmau J, Saiz A, Graus F (2017) Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Mult Scler 24-13:1753–1759. https://doi.org/10.1177/1352458517731914
doi: 10.1177/1352458517731914
Beauchemin P, Iorio R, Traboulsee AL, Field T, Tinker AV, Carruthers R (2017) Paraneoplastic neuromyelitis optica spectrum disorder: a single center cohort description with two cases of histological validation. Mult Scler Relat Disord 20:37–42. https://doi.org/10.1016/j.msard.2017.12.012
doi: 10.1016/j.msard.2017.12.012 pubmed: 29291482
Pittock SJ, Lennon VA (2008) Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65:629–632. https://doi.org/10.1001/archneur.65.5.629
doi: 10.1001/archneur.65.5.629 pubmed: 18474738
Blackburn K, Wang C, Greenberg B (2020) Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma. J Neuroimmunol 338:577092. https://doi.org/10.1016/j.jneuroim.2019.577092
doi: 10.1016/j.jneuroim.2019.577092 pubmed: 31706113
Liao W, Li C, Tang Y, Huang F, Kuang H, Liang S, Yang Y (2019) Aquaporin-4 antibody positive short transverse myelitis associated with breast cancer. Mult Scler Relat Disord 30:119–122. https://doi.org/10.1016/j.msard.2019.02.011
doi: 10.1016/j.msard.2019.02.011 pubmed: 30771577
Deuel LM, Bunch ME (2018) A case of paraneoplastic neuromyelitis optica associated with small cell lung carcinoma. J Neuroimmunol 316:130–132. https://doi.org/10.1016/j.jneuroim.2018.01.003
doi: 10.1016/j.jneuroim.2018.01.003 pubmed: 29317098
Candeias da Silva C, Bichuetti DB, Azevedo Silva SMC, Ferraz HB, Oliveira EML, Borges V (2018) Movement disorders in multiple sclerosis and neuromyelitis optica: a clinical marker of neurological disability. Parkinsonism Relat Disord 51:73–78. https://doi.org/10.1016/j.parkreldis.2018.03.001
doi: 10.1016/j.parkreldis.2018.03.001 pubmed: 29530725
Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, San Miguel J, Avet-Loiseau H, Hajek R, Chen WM, Anderson KC, Ludwig H, Sonneveld P, Pavlovsky S, Palumbo A, Richardson PG, Barlogie B, Greipp P, Vescio R, Turesson I, Westin J, Boccadoro M, International Myeloma Working Group (2010) Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 24:1121–1127. https://doi.org/10.1038/leu.2010.60
doi: 10.1038/leu.2010.60 pubmed: 20410922 pmcid: 7020664
Sudo A, Chihara N, Takenaka Y, Nakamura T, Ueda T, Sekiguchi K, Toda T (2018) Paraneoplastic NMOSD associated with EG junction adenocarcinoma expressing unprotected AQP4. Neurol Neuroimmunol Neuroinflamm 5(5):e482. https://doi.org/10.1212/NXI.0000000000000482
doi: 10.1212/NXI.0000000000000482 pubmed: 29998158 pmcid: 6039212
Bernard-Valnet R, Cobo-Calvo A, Siegfried A, Marasescu R, Bonnan M, Ballan G, Ellie E, Bauer J, Uro-Coste E, Marignier R, Brassat D (2019) Paraneoplastic neuromyelitis optica and ovarian teratoma: a case series. Mult Scler Relat Disord 31:97–100. https://doi.org/10.1016/j.msard.2019.03.031
doi: 10.1016/j.msard.2019.03.031 pubmed: 30954932
Armağan H, Tüzün E, Içöz S, Birişik O, Ulusoy C, Demir G, Altıntaş A, Akman-Demir G (2012) Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment. J Spinal Cord Med 35(4):267–269. https://doi.org/10.1179/2045772312Y.0000000018
doi: 10.1179/2045772312Y.0000000018 pubmed: 22925754 pmcid: 3425884

Auteurs

Eleonora Virgilio (E)

Neurology Unit, Maggiore della Carità Hospital, Department of Translational Medicine, University of Piemonte Orientale, Corso Mazzini 18, 28100, Novara, Italy. virgilioeleonora88@gmail.com.

Domizia Vecchio (D)

Neurology Unit, Maggiore della Carità Hospital, Department of Translational Medicine, University of Piemonte Orientale, Corso Mazzini 18, 28100, Novara, Italy.
Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Novara, Italy.

Marco Vercellino (M)

MS Centre & I Neurology Unit, Department of Neuroscience and Mental Health, City of Health and Science University Hospital of Torino, Via Cherasco 15, Torino, Italy.

Paola Naldi (P)

Neurology Unit, Maggiore della Carità Hospital, Department of Translational Medicine, University of Piemonte Orientale, Corso Mazzini 18, 28100, Novara, Italy.

Fabiana Tesser (F)

Neurology Unit, S. Andrea Hospital, Department of Translational Medicine, University of Piemonte Orientale, Corso Abbiate 21, Vercelli, Italy.

Roberto Cantello (R)

Neurology Unit, Maggiore della Carità Hospital, Department of Translational Medicine, University of Piemonte Orientale, Corso Mazzini 18, 28100, Novara, Italy.

Paola Cavalla (P)

MS Centre & I Neurology Unit, Department of Neuroscience and Mental Health, City of Health and Science University Hospital of Torino, Via Cherasco 15, Torino, Italy.

Cristoforo Comi (C)

Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Novara, Italy.
Neurology Unit, S. Andrea Hospital, Department of Translational Medicine, University of Piemonte Orientale, Corso Abbiate 21, Vercelli, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH